March 20, 2025- Premier submitted comments on a Request for Information (RFI) on the development of an AI action plan issued on behalf of the White House Office of Science and Technology Policy (OSTP). The White House said the AI Action Plan will define priority policy actions to enhance AI leadership within the US while avoiding policies that stifle innovation. In its comments, Premier recommended that the Administration focus its regulatory efforts on:
- Supporting training for the healthcare workforce that combats automation bias and incorporates human decision-making into the use of AI technology in healthcare.
- Publishing clear guidance on patient consent and other requirements to allow for the use of AI-generated synthetic control arms in clinical trials;
- Issuing guidance that supports the industry-wide transition to AI-powered advanced process controls and quality monitoring in drug manufacturing;
- Focusing any future federal AI algorithm transparency requirements on a standardized, outcomes-focused set of metrics;
- Working closely with healthcare technology stakeholders to ensure that any data standards that the federal government codifies align with industry best practices;
- Requiring clear labeling of recommended use(s) to mitigate the risk that an AI algorithm will be applied in a situation for which the model is not appropriate; and